Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens

Rolando D. Z. Lyles; Maria J. Martinez; Benjamin Sherman; Stephan Schürer; Kerry L. Burnstein

doi:10.1371/journal.pone.0287126

Loading metrics

Open Access

Peer-reviewed

Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens

Rolando D. Z. Lyles,

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing

Affiliations Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, Florida, United States of America, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America

https://orcid.org/0000-0001-8518-8513

⨯
Maria J. Martinez,

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing

Affiliations Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America, Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯
Benjamin Sherman,

Roles Methodology, Project administration, Writing – review & editing

Affiliations Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America, Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯
Stephan Schürer,

Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

Affiliations Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America, Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, United States of America
⨯
Kerry L. Burnstein

Roles Conceptualization, Funding acquisition, Methodology, Supervision, Writing – review & editing

* E-mail: kburnstein@med.miami.edu

Affiliations Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States of America, Department of Molecular & Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, United States of America

https://orcid.org/0000-0002-7351-0963

⨯

Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens

Rolando D. Z. Lyles,
Maria J. Martinez,
Benjamin Sherman,
Stephan Schürer,
Kerry L. Burnstein

Published: October 10, 2023
https://doi.org/10.1371/journal.pone.0287126

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Cell viability testing
Is the Subject Area "Cell viability testing" applicable to this article?

Thanks for your feedback.
Cell growth
Is the Subject Area "Cell growth" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
In vivo imaging
Is the Subject Area "In vivo imaging" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.